BioStem Technologies, Inc. (BSEM) insider trading.
In Q3 2026, insiders at BioStem Technologies, Inc. reported 15 non-derivative transactions on 24 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 15
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 10
- Last filed
- 2026-09-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Smith-Van Vurst Andrew | Director, Officer, TenPercentOwner · Chief Operating Officer | 2 | 0 | 0 |
| Matuszewski Jason | Director, Officer, TenPercentOwner · Chief Executive Officer | 2 | 0 | 0 |
| Fortunato Michael A | Officer · Chief Accounting Officer | 2 | 0 | 0 |
| Warrington Kenneth Howard Jr | Director | 2 | 0 | 0 |
| Poe Brandon | Officer · Chief Financial Officer | 2 | 0 | 0 |
| Hassett Barry | Officer · Chief Commercial Officer | 1 | 0 | 0 |
| Glickman Mark A | Director | 1 | 0 | 0 |
| Lesser Hannaway Rayna | Director | 1 | 0 | 0 |
| Sonenreich Steven D | Director | 1 | 0 | 0 |
| Ungrodt Jodi | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Smith-Van Vurst Andrew | M (A) | 9,574 | $0 | 1,539,809 | Form 4 |
| 2026-09-17 | Matuszewski Jason | M (A) | 16,650 | $0 | 1,303,552 | Form 4 |
| 2026-09-15 | Fortunato Michael A | M (A) | 4,234 | $0 | 68,664 | Form 4 |
| 2026-09-15 | Warrington Kenneth Howard Jr | M (A) | 1,694 | $0 | 33,928 | Form 4 |
| 2026-09-15 | Smith-Van Vurst Andrew | M (A) | 7,622 | $0 | 1,530,235 | Form 4 |
| 2026-09-15 | Poe Brandon | M (A) | 1,694 | $0 | 58,062 | Form 4 |
| 2026-09-15 | Matuszewski Jason | M (A) | 8,469 | $0 | 1,286,902 | Form 4 |
| 2026-09-09 | Hassett Barry | M (A) | 500 | $0 | 5,003 | Form 4 |
| 2026-08-27 | Glickman Mark A | M (A) | 7,671 | $0 | 7,671 | Form 4 |
| 2026-08-27 | Lesser Hannaway Rayna | M (A) | 7,671 | $0 | 7,671 | Form 4 |
| 2026-08-27 | Warrington Kenneth Howard Jr | M (A) | 5,094 | $0 | 32,234 | Form 4 |
| 2026-08-27 | Sonenreich Steven D | M (A) | 7,671 | $0 | 7,671 | Form 4 |
| 2026-08-27 | Ungrodt Jodi | M (A) | 5,647 | $0 | 11,295 | Form 4 |
| 2026-08-11 | Poe Brandon | M (A) | 10,634 | $0 | 56,368 | Form 4 |
| 2026-08-09 | Fortunato Michael A | M (A) | 970 | $0 | 64,430 | Form 4 |
Transaction codes in this quarter
Get BSEM insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1658678&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · BSEM company page · BioStem Technologies, Inc. on SEC.gov
Questions
Are insiders buying or selling BioStem Technologies, Inc. (BSEM)?
In Q3 2026, insiders at BioStem Technologies, Inc. reported 15 non-derivative transactions on 24 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these BioStem Technologies, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/bsem.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.